ClinicalTrials.gg
CompletedNCT02035280Updated Jul 28, 2023

Prospective Evaluation of Elderly Deformity Surgery

An observational study in Adult Spinal Deformity, sponsored by AO Foundation, AO Spine. Completed at 13 sites in 8 countries. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2023-07-28.

Sponsored by AO Foundation, AO Spine · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
233
Ages
60 Years and older
Sex
All
01

Study summary

As the population continues to age, the prevalence of spinal deformity surgery for older patients is increasing. Questions regarding the suitability of these patients to undergo large spinal procedures and whether the outcomes merit the risks involved are not well known.

Read the detailed description

225 subjects greater than or equal 60 years of age with moderate and severe adult spinal deformity requiring surgical correction will be enrolled in a prospective multicenter international study. Spinal deformity will be defined as any coronal or sagittal plane spinal deformity in patients who have not undergone any previous spinal surgery (with the exception of prior decompression of a maximum of 2 levels) necessitating at a minimum a 5-level spinal fusion procedure. Standard radiographs and cross sectional imaging will be performed preoperatively, postoperatively, at 24 months and 5 years after surgery. Preoperative disease specific and general health questionnaires will be completed by all patients (EQ-5D, ODI, SRS-22r, NRS for back and leg pain). Follow up visits with questionnaires will be performed at 10 weeks (± 6 weeks), 12 months (± 2 months), 24 months (± 2 months) and 5 years (±6 months) post-operatively. All treatment-related AEs will be documented.

Regression analyses will be used to evaluate the association between patient demographics, comorbidities, treatment history, spinal deformity characteristics, surgical characteristics, treatment-related AEs and pre-surgical status to self-reported and radiographic outcomes after surgery.

02

Conditions studied

  • Adult Spinal Deformity

Keywords

  • Spine
  • Deformity
  • Fusion
  • Elderly
  • SRS-22r
03

In context

Congenital Abnormalities

781 studies on the registry are indexed under Congenital Abnormalities; 77 are open to participants now.

This study's enrollment of 233 is close to the median of 250 across 257 observational studies indexed under Congenital Abnormalities.

Browse Congenital Abnormalities studies →

Lead sponsor

AO Foundation, AO Spine is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Elderly patients undergoing elective surgery for spinal deformity

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 60 years or older at the time of surgery
  • Diagnosis of adult spinal deformity either in the coronal or sagittal plane requiring at the minimum a 5-level spinal fusion procedure
  • Ability to understand the content of the patient information / Form
  • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
  • Signed and dated Institutional Review Board (IRB)/Ethics Committee (EC)-approved written informed consent
  • Reconsent of patients for the 5 year follow-up if required by the IRB/EC

Exclusion criteria

Exclusion Criteria:

  • Any previous spinal procedure (except prior decompression of a maximum of 2 levels)
  • Neurodegenerative disease or paralysis
  • Unlikely to comply with follow-up
  • Institutionalized individuals
  • Any not medically managed severe systemic disease
  • Recent history (≤ 3 months) of substance abuse (ie, recreational drugs, alcohol) or psychosocial disturbance that would preclude reliable assessment
  • Prisoner
  • Presence of active
  • Has active, overt bacterial infection, systemic or local
  • History of recent(≤ 3 months) fracture/malignancy in the spinal region
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
233 participants (actual)
Patient registry
No

Groups and cohorts

  • Elderly suffering of spine deformity

    Spinal deformity patients over the age of 60 years undergoing elective surgery and requiring fusion of at least 5 levels.

06

What researchers measure

Primary outcomes

  1. Absolute change in the Scoliosis Research Society-22 r (SRS-22r) total score

    The primary outcome is the absolute change in the SRS-22r total score between baseline and 24-months follow-up (FU) values in patients at age 60 or older treated with major spinal reconstruction. The SRS-22r is a patient-reported outcome instrument and has a range from 1 (worst) to 5 (best). It contains 22 questions covering five domains: function, pain, self-image, mental health (each with 5 items), and satisfaction with treatment (2 items) and each item is scored from 1 to 5.

    Time frame: Baseline, 10 weeks, 12 months, 24 months

Secondary outcomes

  1. Treatment-related adverse events

    Time frame: Surgery, 10 weeks, 12 months, 24 months, 5 years

  2. Oswestry Disability Index Version 2.1a (ODI)

    The outcome measure is the absolute change between baseline, the 24-month and the 5-year FU values. The ODI is a patient-reported outcome measure used most commonly in patients with low back pain. It consists of 10 questions and each of the items can be scored from 0 (no disability) to 5 (maximal disability), leading to a maximum score of 50.

    Time frame: Baseline, 10 weeks, 12 months, 24 months, 5 years

  3. EuroQoL5 (EQ-5D).

    The EQ-5D is a standardized instrument designed for self-completion to assess quality of life. It has 5 items with a three-point categorical response scale. A unique EQ-5D health state is defined by combining one level from each of the five dimensions. The EQ-5D is a standardized instrument designed for self-completion to assess quality of life. It has 5 items with a three-point categorical response scale. A unique EQ-5D health state is defined by combining one level from each of the five dimensions.

    Time frame: Baseline, 10 weeks, 12 months, 24 months, 5 years

  4. Pain (back and pain)

    The outcome measure is the absolute change between baseline,the 24-month and 5 year FU values. Lower back and leg pain will be assessed on a visual analogue scale (NRS) which ranges from 0 (no pain) to 100 (severe pain).

    Time frame: Baseline, 10 weeks, 12 months, 24 months, 5 years

  5. Bone Mineral Density (BMD)

    Baseline dual energy x-ray absorptiometry (DXA) scans of patients' BMD will only be performed at clinics where assessed as standard of care.

    Time frame: Baseline

  6. Radiological Parameters

    Radiological paramaters (lumbar lordosis, thoracic kyphosis, sagittal vertical axis, Cobb angle) will be measured at one pre- and two post-OP timepoints from sagittal standing and coronal standing x-rays.

    Time frame: Baseline, Surgery, 24 months, 5 years

  7. Animal Fluency Test

    The animal fluency test is a diagnostic tool that is recommended for use in clinical practice for quick assessment of cognitive impairment. The patient names as many animals as possible within a 60-second time period. Fifteen or fewer animals may indicate development of cognitive impairment.

    Time frame: Baseline, 10 weeks, 12 months, 24 months, 5 years

  8. SRS-22r

    The SRS-22r is a patient-reported outcome instrument and has a range from 1 (worst) to 5 (best). It contains 22 questions covering five domains: function, pain, self-image, mental health (each with 5 items), and satisfaction with treatment (2 items) and each item is scored from 1 to 5.

    Time frame: 5 years

07

Study locations

13 sites
  • UCSF Medical Center
    San Francisco, California 94118, United States
  • University of Minnesota
    Minneapolis, Minnesota 55454, United States
  • Washington University Orthopedics
    Saint Louis, Missouri 63110, United States
  • New York Presbyterian - Columbia University Medical Center
    New York, New York 10032, United States
  • University of Virginia
    Charlottesville, Virginia 22903, United States
  • Toronto Western Hospital
    Toronto, Ontario, Canada
  • Queen Mary Hospital
    Hong Kong, China
  • Nanjing University Medical School
    Nanjing, China
  • Rigshospitalet
    Copenhagen, Denmark
  • Hamamatsu University School of Medicine
    Hamamatsu, Japan
  • St. Maartens Kliniek
    Nijmegen, Netherlands
  • Hospital Vall d'Hebron
    Barcelona, Spain
  • Aciboden Maser Hospital
    Istanbul, Turkey
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2013, a primary completion of Dec 2021 and a completion of Dec 2022. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2013
First posted
Jan 14, 2014
Start
Dec 2013
Primary completionActual
Dec 2021
CompletionActual
Dec 2022
Last update
Jul 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02035280
Lead sponsor
AO Foundation, AO Spine
Collaborators
AO Innovation Translation Center
Responsible party
Sponsor
First posted
Jan 14, 2014
Start date
Dec 2013
Primary completion
Dec 2021
Completion
Dec 2022
Last update
Jul 28, 2023

Study contacts

Stephen Lewis, MD
principal investigator · University of Toronto
Sigurd Berven, MD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion